Genolution Statistics

Total Valuation

Genolution has a market cap or net worth of KRW 43.75 billion. The enterprise value is 34.91 billion.

Market Cap	43.75B
Enterprise Value	34.91B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Genolution has 19.19 million shares outstanding. The number of shares has decreased by -1.71% in one year.

Current Share Class	19.19M
Shares Outstanding	19.19M
Shares Change (YoY)	-1.71%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	12.95%
Owned by Institutions (%)	0.04%
Float	14.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.13
PB Ratio	0.54
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.11
EV / Sales	4.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.58

Financial Position

The company has a current ratio of 6.40, with a Debt / Equity ratio of 0.30.

Current Ratio	6.40
Quick Ratio	5.89
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-1.79
Interest Coverage	-21.92

Financial Efficiency

Return on equity (ROE) is -8.58% and return on invested capital (ROIC) is -5.29%.

Return on Equity (ROE)	-8.58%
Return on Assets (ROA)	-5.21%
Return on Invested Capital (ROIC)	-5.29%
Return on Capital Employed (ROCE)	-9.11%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	2.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.49% in the last 52 weeks. The beta is 0.59, so Genolution's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-42.49%
50-Day Moving Average	2,322.80
200-Day Moving Average	2,758.00
Relative Strength Index (RSI)	53.09
Average Volume (20 Days)	32,391

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genolution had revenue of KRW 7.14 billion and -6.83 billion in losses. Loss per share was -378.00.

Revenue	7.14B
Gross Profit	2.30B
Operating Income	-9.16B
Pretax Income	-6.77B
Net Income	-6.83B
EBITDA	-7.12B
EBIT	-9.16B
Loss Per Share	-378.00

Full Income Statement

Balance Sheet

The company has 33.22 billion in cash and 24.27 billion in debt, giving a net cash position of 8.95 billion or 466.37 per share.

Cash & Cash Equivalents	33.22B
Total Debt	24.27B
Net Cash	8.95B
Net Cash Per Share	466.37
Equity (Book Value)	80.40B
Book Value Per Share	4,445.58
Working Capital	31.46B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.43 billion and capital expenditures -12.13 billion, giving a free cash flow of -13.56 billion.

Operating Cash Flow	-1.43B
Capital Expenditures	-12.13B
Free Cash Flow	-13.56B
FCF Per Share	-706.50

Full Cash Flow Statement

Margins

Gross margin is 32.23%, with operating and profit margins of -128.42% and -95.65%.

Gross Margin	32.23%
Operating Margin	-128.42%
Pretax Margin	-94.89%
Profit Margin	-95.65%
EBITDA Margin	-99.82%
EBIT Margin	-128.42%
FCF Margin	n/a

Dividends & Yields

Genolution does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.71%
Shareholder Yield	1.71%
Earnings Yield	-15.60%
FCF Yield	-30.99%

Dividend Details

Stock Splits

The last stock split was on April 19, 2023. It was a forward split with a ratio of 2.

Last Split Date	Apr 19, 2023
Split Type	Forward
Split Ratio	2

Scores

Genolution has an Altman Z-Score of 2.42. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.42
Piotroski F-Score	n/a